NEW YORK (GenomeWeb News) — Shares in Compugen slid 5.53 percent, or $.16, to $2.83 in mid-afternoon trading today after the company reported a 20-percent jump in R&D spending and a 12-percent jump in net loss atop weak revenue.
 
As GenomeWeb News reported this morning, Compugen also said it may need to raise additional cash by the middle of 2009 if it continues spending as it has been.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.